The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype